nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B15—gall bladder—bile duct cancer	0.0462	0.105	CbGeAlD
Valproic Acid—OGDH—pancreas—bile duct cancer	0.0236	0.0535	CbGeAlD
Valproic Acid—UGT2B15—pancreas—bile duct cancer	0.0213	0.0482	CbGeAlD
Valproic Acid—HDAC9—pancreas—bile duct cancer	0.0208	0.0471	CbGeAlD
Valproic Acid—UGT1A10—liver—bile duct cancer	0.0205	0.0463	CbGeAlD
Valproic Acid—UGT1A6—liver—bile duct cancer	0.019	0.043	CbGeAlD
Valproic Acid—ACADSB—pancreas—bile duct cancer	0.0188	0.0425	CbGeAlD
Valproic Acid—UGT1A8—liver—bile duct cancer	0.0162	0.0366	CbGeAlD
Valproic Acid—OGDH—liver—bile duct cancer	0.015	0.034	CbGeAlD
Valproic Acid—UGT1A3—liver—bile duct cancer	0.0144	0.0326	CbGeAlD
Valproic Acid—ABAT—pancreas—bile duct cancer	0.0141	0.032	CbGeAlD
Valproic Acid—UGT2B15—liver—bile duct cancer	0.0136	0.0307	CbGeAlD
Valproic Acid—UGT1A4—liver—bile duct cancer	0.0123	0.0277	CbGeAlD
Valproic Acid—ACADSB—liver—bile duct cancer	0.0119	0.027	CbGeAlD
Valproic Acid—OGDH—lymph node—bile duct cancer	0.0115	0.0261	CbGeAlD
Valproic Acid—HDAC2—pancreas—bile duct cancer	0.0107	0.0241	CbGeAlD
Valproic Acid—ALDH5A1—liver—bile duct cancer	0.0105	0.0238	CbGeAlD
Valproic Acid—UGT1A9—liver—bile duct cancer	0.0103	0.0232	CbGeAlD
Valproic Acid—HDAC9—lymph node—bile duct cancer	0.0102	0.023	CbGeAlD
Valproic Acid—ACADSB—lymph node—bile duct cancer	0.00916	0.0207	CbGeAlD
Valproic Acid—ABAT—liver—bile duct cancer	0.009	0.0204	CbGeAlD
Valproic Acid—CYP2C18—liver—bile duct cancer	0.00898	0.0203	CbGeAlD
Valproic Acid—UGT2B7—liver—bile duct cancer	0.00828	0.0187	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—bile duct cancer	0.00806	0.0182	CbGeAlD
Valproic Acid—SLC22A7—liver—bile duct cancer	0.00788	0.0178	CbGeAlD
Valproic Acid—ABAT—lymph node—bile duct cancer	0.0069	0.0156	CbGeAlD
Valproic Acid—HDAC2—liver—bile duct cancer	0.00678	0.0153	CbGeAlD
Valproic Acid—SLC16A1—liver—bile duct cancer	0.00602	0.0136	CbGeAlD
Valproic Acid—CYP2A6—liver—bile duct cancer	0.00593	0.0134	CbGeAlD
Valproic Acid—HDAC2—lymph node—bile duct cancer	0.0052	0.0118	CbGeAlD
Valproic Acid—CYP3A5—pancreas—bile duct cancer	0.00473	0.0107	CbGeAlD
Valproic Acid—SLC16A1—lymph node—bile duct cancer	0.00462	0.0104	CbGeAlD
Valproic Acid—CYP2C19—liver—bile duct cancer	0.00382	0.00863	CbGeAlD
Valproic Acid—SLC22A5—liver—bile duct cancer	0.00344	0.00778	CbGeAlD
Valproic Acid—CYP2C8—liver—bile duct cancer	0.00333	0.00753	CbGeAlD
Valproic Acid—CYP1A2—liver—bile duct cancer	0.00312	0.00705	CbGeAlD
Valproic Acid—CYP3A5—liver—bile duct cancer	0.00301	0.0068	CbGeAlD
Valproic Acid—CYP2B6—liver—bile duct cancer	0.00299	0.00676	CbGeAlD
Valproic Acid—CYP2C9—liver—bile duct cancer	0.00296	0.00669	CbGeAlD
Valproic Acid—SLC22A5—lymph node—bile duct cancer	0.00264	0.00597	CbGeAlD
Valproic Acid—CYP3A4—liver—bile duct cancer	0.00226	0.0051	CbGeAlD
Valproic Acid—PTGS1—lymph node—bile duct cancer	0.00207	0.00468	CbGeAlD
Valproic Acid—OGDH—Metabolism—SLC5A5—bile duct cancer	0.0011	0.00197	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00109	0.00196	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—HGF—bile duct cancer	0.00109	0.00195	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RNF43—bile duct cancer	0.00106	0.0019	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—MMP2—bile duct cancer	0.00105	0.00188	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—IDH2—bile duct cancer	0.00105	0.00188	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00103	0.00185	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—IDH1—bile duct cancer	0.00103	0.00185	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.00101	0.00181	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—GNAS—bile duct cancer	0.00101	0.0018	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—FAR2—bile duct cancer	0.001	0.0018	CbGpPWpGaD
Valproic Acid—UGT1A6—NRF2 pathway—TGFB1—bile duct cancer	0.000997	0.00179	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—FAR2—bile duct cancer	0.000977	0.00175	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000938	0.00168	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000931	0.00167	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000922	0.00165	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—NOS2—bile duct cancer	0.000914	0.00164	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFBR2—bile duct cancer	0.00091	0.00163	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—IDH1—bile duct cancer	0.000901	0.00161	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—IDH2—bile duct cancer	0.000874	0.00157	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.000868	0.00155	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—GNAS—bile duct cancer	0.000855	0.00153	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—HRAS—bile duct cancer	0.000846	0.00152	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000838	0.0015	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000837	0.0015	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—HGF—bile duct cancer	0.000837	0.0015	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TGFB1—bile duct cancer	0.000836	0.0015	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.00082	0.00147	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—FAR2—bile duct cancer	0.000794	0.00142	CbGpPWpGaD
Valproic Acid—UGT1A4—NRF2 pathway—TGFB1—bile duct cancer	0.00077	0.00138	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000764	0.00137	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MBD2—bile duct cancer	0.000761	0.00136	CbGpPWpGaD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000759	0.00136	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—IDH1—bile duct cancer	0.000752	0.00135	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.000751	0.00135	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000748	0.00134	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000748	0.00134	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.000737	0.00132	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000729	0.00131	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFBR2—bile duct cancer	0.000692	0.00124	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—bile duct cancer	0.000689	0.00123	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—SLC5A5—bile duct cancer	0.00068	0.00122	CbGpPWpGaD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000678	0.00121	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—IDH2—bile duct cancer	0.000675	0.00121	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000674	0.00121	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RNF43—bile duct cancer	0.000657	0.00118	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SMAD4—bile duct cancer	0.000655	0.00117	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—GNAS—bile duct cancer	0.000654	0.00117	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—bile duct cancer	0.000653	0.00117	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000653	0.00117	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—FAR2—bile duct cancer	0.000647	0.00116	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—HRAS—bile duct cancer	0.000641	0.00115	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—TGFB1—bile duct cancer	0.00064	0.00115	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—bile duct cancer	0.000637	0.00114	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000627	0.00112	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HGF—bile duct cancer	0.000623	0.00112	CbGpPWpGaD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000618	0.00111	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—FAR2—bile duct cancer	0.000612	0.0011	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00061	0.00109	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—IDH2—bile duct cancer	0.000602	0.00108	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—GNAS—bile duct cancer	0.000598	0.00107	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—SLC5A5—bile duct cancer	0.000594	0.00107	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—IDH1—bile duct cancer	0.00058	0.00104	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HGF—bile duct cancer	0.00057	0.00102	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000567	0.00102	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000566	0.00101	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IDH1—bile duct cancer	0.000565	0.00101	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000564	0.00101	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—IDH2—bile duct cancer	0.000561	0.00101	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—bile duct cancer	0.000547	0.00098	CbGpPWpGaD
Valproic Acid—UGT2B7—NRF2 pathway—TGFB1—bile duct cancer	0.000544	0.000976	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PTGS2—bile duct cancer	0.00054	0.000968	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—bile duct cancer	0.000534	0.000958	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GNAS—bile duct cancer	0.000528	0.000947	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000528	0.000946	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000524	0.000939	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—ERBB2—bile duct cancer	0.000519	0.00093	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—IDH1—bile duct cancer	0.000517	0.000927	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—SLC5A5—bile duct cancer	0.000496	0.000889	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—FAR2—bile duct cancer	0.000494	0.000885	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—IDH2—bile duct cancer	0.00049	0.000879	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NOS2—bile duct cancer	0.000488	0.000874	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000487	0.000873	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFBR2—bile duct cancer	0.000485	0.000869	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—FAR2—bile duct cancer	0.000483	0.000865	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—IDH1—bile duct cancer	0.000482	0.000865	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NOS2—bile duct cancer	0.000478	0.000856	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—IDH2—bile duct cancer	0.000477	0.000855	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000473	0.000848	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GNAS—bile duct cancer	0.000468	0.000838	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GNAS—bile duct cancer	0.000462	0.000828	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RNF43—bile duct cancer	0.00046	0.000825	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTGS2—bile duct cancer	0.000459	0.000823	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SMAD4—bile duct cancer	0.000459	0.000823	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—TGFB1—bile duct cancer	0.000442	0.000793	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00044	0.000789	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000439	0.000787	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NOS2—bile duct cancer	0.000437	0.000783	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—IDH1—bile duct cancer	0.000422	0.000756	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—FAR2—bile duct cancer	0.000418	0.000749	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—IDH1—bile duct cancer	0.00041	0.000735	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000408	0.000731	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	0.000407	0.00073	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—bile duct cancer	0.0004	0.000717	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.0004	0.000717	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.0004	0.000717	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NRAS—bile duct cancer	0.000395	0.000707	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000394	0.000706	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—IDH2—bile duct cancer	0.000388	0.000695	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GNAS—bile duct cancer	0.000385	0.000691	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SLC5A5—bile duct cancer	0.000383	0.000686	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000378	0.000678	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—FAR2—bile duct cancer	0.000373	0.000669	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000367	0.000659	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ERBB2—bile duct cancer	0.000367	0.000658	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—IL6—bile duct cancer	0.000366	0.000657	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—bile duct cancer	0.000359	0.000644	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—bile duct cancer	0.000359	0.000643	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000352	0.000631	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SLC5A5—bile duct cancer	0.000341	0.000612	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFB1—bile duct cancer	0.000341	0.000611	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FAR2—bile duct cancer	0.00034	0.00061	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KRAS—bile duct cancer	0.00034	0.000609	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—IDH1—bile duct cancer	0.000333	0.000597	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000321	0.000576	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000321	0.000575	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC5A5—bile duct cancer	0.000318	0.00057	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—IDH2—bile duct cancer	0.000316	0.000566	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—SMAD4—bile duct cancer	0.000306	0.000549	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFBR2—bile duct cancer	0.0003	0.000538	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—IDH2—bile duct cancer	0.000299	0.000536	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GNAS—bile duct cancer	0.000298	0.000533	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FAR2—bile duct cancer	0.000291	0.000521	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—bile duct cancer	0.000289	0.000517	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SMAD4—bile duct cancer	0.000284	0.000509	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—bile duct cancer	0.000284	0.000508	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—bile duct cancer	0.000279	0.0005	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC5A5—bile duct cancer	0.000278	0.000499	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—bile duct cancer	0.000276	0.000495	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000274	0.000491	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—bile duct cancer	0.000273	0.00049	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—IDH1—bile duct cancer	0.000272	0.000487	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC5A5—bile duct cancer	0.000271	0.000485	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GNAS—bile duct cancer	0.000265	0.000475	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—bile duct cancer	0.000259	0.000465	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—IDH1—bile duct cancer	0.000257	0.000461	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ERBB2—bile duct cancer	0.000257	0.00046	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—bile duct cancer	0.000254	0.000456	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—bile duct cancer	0.000254	0.000455	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—bile duct cancer	0.00025	0.000448	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—bile duct cancer	0.000248	0.000444	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GNAS—bile duct cancer	0.000247	0.000443	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—IDH2—bile duct cancer	0.000241	0.000432	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KRAS—bile duct cancer	0.00024	0.000431	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—IDH2—bile duct cancer	0.000236	0.000422	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—bile duct cancer	0.000235	0.000422	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—bile duct cancer	0.000232	0.000416	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000224	0.000402	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MMP9—bile duct cancer	0.00022	0.000395	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC5A5—bile duct cancer	0.00022	0.000394	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GNAS—bile duct cancer	0.000216	0.000387	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—bile duct cancer	0.000215	0.000386	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NOS2—bile duct cancer	0.000212	0.000379	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GNAS—bile duct cancer	0.00021	0.000377	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFBR2—bile duct cancer	0.00021	0.000377	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—bile duct cancer	0.000209	0.000375	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—IDH1—bile duct cancer	0.000207	0.000372	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—bile duct cancer	0.000207	0.000371	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000206	0.000369	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—bile duct cancer	0.000204	0.000366	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—IDH2—bile duct cancer	0.000204	0.000366	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GNAS—bile duct cancer	0.000203	0.000364	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—IDH1—bile duct cancer	0.000203	0.000363	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—bile duct cancer	0.0002	0.000358	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMAD4—bile duct cancer	0.000199	0.000357	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—bile duct cancer	0.000195	0.00035	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—bile duct cancer	0.000195	0.00035	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—bile duct cancer	0.000191	0.000343	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—bile duct cancer	0.000183	0.000328	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—IDH2—bile duct cancer	0.000182	0.000327	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—bile duct cancer	0.000182	0.000326	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC5A5—bile duct cancer	0.000179	0.000321	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—bile duct cancer	0.000178	0.000319	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—IDH1—bile duct cancer	0.000176	0.000315	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNAS—bile duct cancer	0.000171	0.000306	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC5A5—bile duct cancer	0.00017	0.000304	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—bile duct cancer	0.000168	0.000301	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000168	0.000301	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—IDH2—bile duct cancer	0.000166	0.000298	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—bile duct cancer	0.00016	0.000286	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—bile duct cancer	0.000159	0.000285	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—IDH1—bile duct cancer	0.000157	0.000281	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—bile duct cancer	0.000156	0.000279	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—bile duct cancer	0.000149	0.000268	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—bile duct cancer	0.000143	0.000256	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—IDH1—bile duct cancer	0.000143	0.000256	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—bile duct cancer	0.000142	0.000255	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000142	0.000254	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNAS—bile duct cancer	0.000139	0.00025	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—bile duct cancer	0.000137	0.000245	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC5A5—bile duct cancer	0.000137	0.000245	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC5A5—bile duct cancer	0.000134	0.00024	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—bile duct cancer	0.000133	0.000238	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNAS—bile duct cancer	0.000132	0.000236	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000122	0.000219	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—bile duct cancer	0.000121	0.000217	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—bile duct cancer	0.000116	0.000208	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—bile duct cancer	0.000116	0.000208	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—bile duct cancer	0.000113	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—bile duct cancer	0.000112	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—bile duct cancer	0.000111	0.0002	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—bile duct cancer	0.00011	0.000198	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH2—bile duct cancer	0.00011	0.000196	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000109	0.000194	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNAS—bile duct cancer	0.000106	0.000191	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—bile duct cancer	0.000104	0.000187	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNAS—bile duct cancer	0.000104	0.000186	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—bile duct cancer	0.000103	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	9.69e-05	0.000174	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—bile duct cancer	9.55e-05	0.000171	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—bile duct cancer	9.42e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH1—bile duct cancer	9.42e-05	0.000169	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—bile duct cancer	9.18e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNAS—bile duct cancer	9e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—bile duct cancer	8.85e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	8.83e-05	0.000158	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—bile duct cancer	8.47e-05	0.000152	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—bile duct cancer	8.47e-05	0.000152	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—bile duct cancer	8.05e-05	0.000144	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNAS—bile duct cancer	8.03e-05	0.000144	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—bile duct cancer	7.87e-05	0.000141	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—bile duct cancer	7.72e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.55e-05	0.000135	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—bile duct cancer	7.48e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNAS—bile duct cancer	7.32e-05	0.000131	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—bile duct cancer	7.29e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—bile duct cancer	7.07e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—bile duct cancer	6.48e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNAS—bile duct cancer	6.26e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—bile duct cancer	6.22e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—bile duct cancer	6.2e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—bile duct cancer	5.93e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—bile duct cancer	5.71e-05	0.000102	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—bile duct cancer	5.58e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—bile duct cancer	4.83e-05	8.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNAS—bile duct cancer	4.83e-05	8.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—bile duct cancer	4.31e-05	7.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—bile duct cancer	3.93e-05	7.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—bile duct cancer	3.36e-05	6.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—bile duct cancer	2.59e-05	4.65e-05	CbGpPWpGaD
